Get App
PRE MARKET
Gift Nifty indicates a positive start for the broader index in India, with a gain of 63.5 points or 0.25 percent. The Nifty futures were trading around the 25,156 level.
Technology shares boosted U.S. stocks to a higher close on Wednesday as investors, lacking economic data during the government shutdown, looked to minutes from the Federal Reserve’s most recent policy meeting for clues to the outlook for interest rates.
The S&P 500 and the Nasdaq notched all-time closing highs, while the Dow ended essentially flat. The Dow Jones Industrial Average fell 1.20 points, or 0.00%, to 46,601.78, the S&P 500 gained 39.13 points, or 0.58%, to 6,753.72, and the Nasdaq Composite gained 255.02 points, or 1.12%, to 23,043.38.
Asian stock markets resumed their ascent on Thursday as investors doubled down on all things AI-related, while gold held atop $4,000 and the dollar retained its recent hefty gains.
Japan’s Nikkei and the Taiwanese weighted index went up 1.46 percent and 1.23 percent, while the Hong Kong Hang Seng went down 1.02 percent.
STOCKS TODAY
IRB Invit Fund
The infrastructure investment trust launched its Qualified Institutions Placement (QIP) on October 8 with a floor price of Rs 62.69 per unit. According to CNBC-TV18 sources, the QIP size is likely to be around Rs 3,000 crore, with an upsize option of Rs 250 crore.
GR Infraprojects
The company has received a Letter of Acceptance (LoA) from the Jharkhand Highway Authority for a road construction project worth Rs 290.23 crore. The EPC project involves the construction of the Giridih Bypass (towards Tundi) road.
Garuda Construction and Engineering
The company has received orders worth Rs 143.96 crore from Orbit Ventures Developers for civil work on a redevelopment project — Shikhar-B — at Oshiwara, Mumbai. The total order book of the company stands at Rs 3,229.78 crore as of October 8.
Lupin
The pharmaceutical company has announced plans to build a new pharmaceutical manufacturing plant in Coral Springs, Florida, USA. With a projected investment of $250 million — including research & development, infrastructure, and capital expenditures over five years — the new site will have the capacity to accommodate the production of more than 25 critical respiratory medicines.
Oswal Agro Mills
Narinder Kumar has decided to step down from the position of Whole-time Director and CEO of the company due to other personal commitments, effective October 8.
Source – Moneycontrol